Chemotherapy before surgery for blocked colon cancer
Treatments studied
Part of Cancer, Digestive system, Injuries & trauma clinical trials.
This trial tests whether giving chemotherapy before surgery can help people with colon cancer that is blocking the bowel. The goal is to see if this approach improves outcomes and makes surgery safer or more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 74 years old.
- You have stage II or III colon cancer that is causing a blockage in the bowel.
- You have had a stent (a small tube) placed to open the blockage, and it worked well within 48 hours.
- You are generally healthy enough for chemotherapy (good organ function, no serious other illnesses).
- You are not pregnant or breastfeeding, and you agree to use contraception if needed.
- You have not had a severe allergic reaction to the chemotherapy drugs used in this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy before surgery helps people with colon cancer that caused a blockage and needed a temporary colostomy. It aims to improve outcomes compared to standard treatment.
This trial tests whether giving chemotherapy before surgery can improve outcomes for patients with colon cancer that has not spread to other parts of the body. The treatment aims to shrink the tumor and reduce the chance of the cancer coming back.
This trial compares giving chemotherapy before surgery versus going straight to surgery for certain stage II/III colon cancers. It may help shrink the tumor and improve outcomes by testing which approach works best for high-risk cases.
This Phase 2 trial studies giving chemotherapy plus immune therapy before surgery for certain colon cancers that do not have mismatch repair defects (MSS/pMMR). The goal is to shrink and control the tumor and improve outcomes compared with standard approaches.
This trial compares giving chemotherapy before surgery versus going straight to surgery for people with locally advanced colon cancer and a high CEA blood marker. It aims to see if the chemo-first approach improves outcomes.
This trial tests whether giving chemotherapy followed by an immunotherapy drug (a checkpoint inhibitor) before surgery helps shrink locally advanced colon cancer. It is for people with a specific tumor type (MSS and RAS mutation) who have not had prior treatment.
Hear when a new Colon Cancer, Obstruction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.